Ligand id: 8959

Name: ensartinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 113.68
Molecular weight 546.13
XLogP 3.4
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
X-396 is being evaluated in Phase I/II clinical trial for its potential to treat ALK-positive non-small cell lung cancer (NSCLC)- see clinical trial NCT01625234.